The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System

Open Access

Peer-reviewed

Research Article

Sean M. Geary,

Affiliation Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, United States of America
⨯
Caitlin D. Lemke,

Affiliation Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, United States of America
⨯
David M. Lubaroff,

Affiliation Departments of Urology and Microbiology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, United States of America
⨯
Aliasger K. Salem

* E-mail: aliasger-salem@uiowa.edu

Affiliation Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, United States of America
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Lymph nodes
Is the Subject Area "Lymph nodes" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cancer vaccines
Is the Subject Area "Cancer vaccines" applicable to this article?

Thanks for your feedback.